A7290912
Sulfadiazine , Analysis standard , 68-35-9
Synonym(s):
N1-(Pyrimidin-2-yl)sulfanilamide;4-Amino-N-(2-pyrimidinyl)benzenesulfonamide;Sulfadiazine
CAS NO.：68-35-9
Empirical Formula: C10H10N4O2S
Molecular Weight: 250.28
MDL number: MFCD00006065
EINECS: 200-685-8
| Pack Size | Price | Stock | Quantity |
| 100MG | RMB235.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 253 °C (dec.) (lit.) |
| Boiling point: | 512.6±52.0 °C(Predicted) |
| Density | 1.3780 (rough estimate) |
| refractive index | 1.6440 (estimate) |
| storage temp. | 2-8°C |
| solubility | Soluble in dimethyl sulfoxide. |
| pka | pKa 2.21(H2O
t = 25
I = 0.5 (NaCl)) (Uncertain) |
| form | powder |
| color | white |
| Water Solubility | 67.13mg/L(25 ºC) |
| Merck | 14,8903 |
| BRN | 6733588 |
| BCS Class | 4/3 |
| CAS DataBase Reference | 68-35-9(CAS DataBase Reference) |
| NIST Chemistry Reference | Sulfadiazine(68-35-9) |
| EPA Substance Registry System | Benzenesulfonamide, 4-amino-N-2-pyrimidinyl- (68-35-9) |
Description and Uses
DMSO soluble potent immunosuppressant, neuroprotective neuroregenerative, in vitro T cell proliferation blocker. disrupts calcineurin-mediated signal transduction in T lymphocytes
Safety
| Symbol(GHS) |    GHS07,GHS08,GHS09 |
| Signal word | Warning |
| Hazard statements | H302-H361d-H362-H411 |
| Precautionary statements | P202-P260-P263-P273-P301+P312-P308+P313 |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-36/37/38-42/43-43-42 |
| Safety Statements | 26-36 |
| RIDADR | 3249 |
| WGK Germany | 3 |
| RTECS | WP1925000 |
| F | 10 |
| TSCA | Yes |
| HazardClass | 6.1(b) |
| PackingGroup | III |
| HS Code | 29335990 |
| Toxicity | LD50 oral in mouse: 1500mg/kg |
